Skip to content
No picture yet

Premarin 1.25 mg – DIN 02414694

Premarin is Conjugated Estrogens 1.25 mg (tablet (extended-release)), sold in Canada. It is used for hot flashes, low testosterone and breast cancer. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Conjugated Estrogens 1.25 mg

Brand
Premarin
Strength
1.25 mg
Used for
Hot flashes, low testosterone and breast cancer
Form
Tablet (extended-release)
Manufacturer
Pfizer Canada ULC
Drug class
Estrogen hormone
Sold in
Canada
DIN
02414694

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Conjugated Estrogens pills and guides

What is Conjugated Estrogens used for?

Conjugated Estrogens is used for hot flashes, low testosterone, breast cancer and prostate cancer.

Medicine type
Estrogen hormone
Official uses from the US prescribing label

PREMARIN therapy is indicated in the:

  1. Treatment of moderate to severe vasomotor symptoms due to menopause.
  2. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
  3. Treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure.
  4. Treatment of breast cancer (for palliation only) in appropriately selected women and men with metastatic disease.
  5. Treatment of advanced androgen-dependent carcinoma of the prostate (for palliation only).
  6. Prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate. (See CLINICAL STUDIES.) The mainstays for decreasing the risk of postmenopausal osteoporosis are weight-bearing exercise, adequate calcium and vitamin D intake, and when indicated, pharmacologic therapy. Postmenopausal women require an average of 1500 mg/day of elemental calcium. Therefore, when not contraindicated, calcium supplementation may be helpful for women with suboptimal dietary intake. Vitamin D supplementation of 400-800 IU/day may also be required to ensure adequate daily intake in postmenopausal women.

From the FDA-approved label on DailyMed (published May 13, 2014).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02414694.
  • It names Premarin, Conjugated Estrogens 1.25 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Premarin sustained-release by Pfizer Canada ULC.

In Canada: prescription only.

Ingredients

Active: Conjugated Estrogens

Other Conjugated Estrogens pills